316 related articles for article (PubMed ID: 9255199)
21. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
22. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
23. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
[TBL] [Abstract][Full Text] [Related]
24. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
25. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
[TBL] [Abstract][Full Text] [Related]
26. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
[TBL] [Abstract][Full Text] [Related]
27. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
Eshraghian A; Imanieh MH; Dehghani SM; Nikeghbalian S; Shamsaeefar A; Barshans F; Kazemi K; Geramizadeh B; Malek-Hosseini SA
World J Gastroenterol; 2017 Feb; 23(7):1224-1232. PubMed ID: 28275302
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
Berney T; Delis S; Kato T; Nishida S; Mittal NK; Madariaga J; Levi D; Nery JR; Cirocco RE; Gelman B; Ruiz P; Tzakis AG
Transplantation; 2002 Oct; 74(7):1000-6. PubMed ID: 12394845
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.
Hierro L; Díez-Dorado R; Díaz C; De la Vega A; Frauca E; Camarena C; Muñoz-Bartolo G; González de Zárate A; López Santamaría M; Jara P
Liver Transpl; 2008 Aug; 14(8):1185-93. PubMed ID: 18668670
[TBL] [Abstract][Full Text] [Related]
31. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
McDiarmid S; Goss J; Seu P; Shackleton C; Vargas J; Ament M; Busuttil R
Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
[No Abstract] [Full Text] [Related]
32. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
[TBL] [Abstract][Full Text] [Related]
33. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival after post-transplant lymphoproliferative disease in children.
Nathanson S; Debray D; Delarue A; Deschênes G
Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
[TBL] [Abstract][Full Text] [Related]
35. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
[TBL] [Abstract][Full Text] [Related]
36. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.
Fridell JA; Jain A; Reyes J; Biederman R; Green M; Sindhi R; Mazariegos GV
Transplantation; 2002 Dec; 74(12):1721-4. PubMed ID: 12499888
[TBL] [Abstract][Full Text] [Related]
37. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
Quintini C; Kato T; Gaynor JJ; Ueno T; Selvaggi G; Gordon P; McLaughlin G; Tompson J; Ruiz P; Tzakis A
Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
[TBL] [Abstract][Full Text] [Related]
38. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
[TBL] [Abstract][Full Text] [Related]
39. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.
Mañez R; Breinig MC; Linden P; Wilson J; Torre-Cisneros J; Kusne S; Dummer S; Ho M
J Infect Dis; 1997 Dec; 176(6):1462-7. PubMed ID: 9395355
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]